Results 11 to 20 of about 9,511 (209)

Proliferative Vitreoretinopathy: A Reappraisal [PDF]

open access: yesJournal of Clinical Medicine, 2023
Proliferative vitreoretinopathy (PVR) remains the main cause of failure after retinal detachment (RD) surgery. Despite the development of modern technologies and sophisticated techniques for the management of RD, the growth of fibrocellular membranes within the vitreous cavity and on both sides of the retinal surface, as well as intraretinal fibrosis ...
Paolo Carpineto
exaly   +5 more sources

A Review of Innovations in Rhegmatogenous Retinal Detachment Surgical Techniques [PDF]

open access: yesJournal of Ophthalmology, 2017
Rhegmatogenous retinal detachment (RRD) requires surgical intervention for its repair. There are variable techniques used for this purpose, and they are all being continuously refined.
Achia Nemet   +4 more
doaj   +4 more sources

Leveraging AAV1-Rac1T17N to prevent experimental proliferative vitreoretinopathy [PDF]

open access: yesJournal of Translational Medicine
Background Platelet-derived growth factor receptor β (PDGFRβ) is the principal PDGFR isoform in retinal pigment epithelial (RPE) cells from the epiretinal membranes of patients with proliferative vitreoretinopathy (PVR).
Duo Li   +8 more
doaj   +2 more sources

APRI and FIB-4 indices as systemic fibrosis markers in proliferative vitreoretinopathy [PDF]

open access: yesBMC Ophthalmology
Objective This study aimed to investigate the relationship between systemic fibrosis markers, including the Aspartate Aminotransferase–to–Platelet Ratio Index (APRI) and the Fibrosis-4 Index (FIB-4), and the development of proliferative vitreoretinopathy
Eda Zeynep Kılıç, Nurullah Koçak
doaj   +2 more sources

Proliferative vitreoretinopathy

open access: yesZdravniški Vestnik, 2005
Background: Proliferative vitreoretinopathy (PVR) is a disease characterized by formation of membranes on both surfaces of the retina and vitreous base. PVR is a wound healing response which is inadequate and uncontrolled in the eye. Identifying the risk
Mojca Globočnik-Petrovič   +1 more
doaj   +3 more sources

Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice [PDF]

open access: yesNature Communications
Proliferative vitreoretinopathy is a vision-threatening response to penetrating ocular injury, for which there is no satisfactory treatment. In this disorder, retinal pigment epithelial cells, abandon their attachment to Bruch’s membrane on the scleral ...
Min Luo   +7 more
doaj   +2 more sources

A sustained dual drug delivery system for proliferative vitreoretinopathy

open access: yesDrug Delivery, 2020
Proliferative vitreoretinopathy (PVR) is a significant threat for vision recovery from retinal detachment or ocular trauma. Currently, no approved pharmacological intervention to prevent PVR.
David Warther   +2 more
exaly   +2 more sources

Proliferative vitreoretinopathy and its relationship with inflammatory serum biomarkers [PDF]

open access: yesInternational Journal of Ophthalmology
AIM: To analyze if a relationship between levels of inflammatory serum biomarkers and severity of primary proliferative vitreoretinopathy (PVR) exists. METHODS: A retrospective case-control study.
Victor Alejandro Martinez Pacheco   +3 more
doaj   +2 more sources

Risk factors for failure after primary vitrectomy with no scleral buckling for rhegmatogenous retinal detachment [PDF]

open access: yesRevista Brasileira de Oftalmologia, 2023
Objective To assess pre-operative conditions that could influence primary anatomical success rate in a cohort of patients with rhegmatogenous retinal detachments (RRD) treated with primary vitrectomy and no scleral buckling.
Mariano Iros   +4 more
doaj   +1 more source

Effects of repeated intra-silicone oil injections of methotrexate on proliferative vitreoretinopathy grade C: a multicenter randomized controlled trial [PDF]

open access: yesScientific Reports
In this randomized controlled trial, we assessed the effects of three consecutive intra-silicone oil (SO) injections of methotrexate (MTX) on the outcomes of surgery for proliferative vitreoretinopathy grade C (PVR-C).
Ramin Nourinia   +30 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy